Ocular manifestations of COVID-19: A systematic review of current evidence
- PMID: 38375172
- PMCID: PMC10874879
- DOI: 10.1016/j.pmedr.2024.102608
Ocular manifestations of COVID-19: A systematic review of current evidence
Abstract
Introduction: COVID-19 caused by SARS-CoV-2, commonly presents with symptoms such as fever and shortness of breath but can also affect other organs. There is growing evidence pointing to potential eye complications. In this article, we aim to systematically review the ocular manifestations of COVID-19.
Methods: We conducted a systematic review to explore the ocular manifestations of COVID-19. We searched online databases including PubMed, Embase, Scopus, and Web of Science up to September 4, 2023. After a two-stage screening process and applying inclusion/exclusion criteria, eligible articles were advanced to the data extraction phase. The PRISMA checklist and Newcastle-Ottawa Scale (NOS) were used for quality and bias risk assessments.
Results: We selected and extracted data from 42 articles. Most of the studies were cross-sectional (n = 33), with the highest number conducted in Turkey (n = 10). The most frequent ocular manifestation was conjunctivitis, reported in 24 articles, followed by photophobia, burning, chemosis, itching, and ocular pain. Most studies reported complete recovery from these manifestations; however, one study mentioned visual loss in two patients.
Conclusion: In general, ocular manifestations of COVID-19 appear to resolve either spontaneously or with supportive treatments. For more severe cases, both medical treatment and surgery have been employed, with the outcomes suggesting that complete recoveries are attainable.
Keywords: COVID-19; Eye involvement; Ocular manifestations; Ophthalmic complication.
© 2024 The Authors.
Conflict of interest statement
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Figures
Similar articles
-
Ocular Manifestations of COVID-19: A Systematic Review and Meta-analysis.J Ophthalmic Vis Res. 2021 Jan 20;16(1):103-112. doi: 10.18502/jovr.v16i1.8256. eCollection 2021 Jan-Mar. J Ophthalmic Vis Res. 2021. PMID: 33520133 Free PMC article.
-
Pooled Prevalence Estimate of Ocular Manifestations in COVID-19 Patients: A Systematic Review and Meta-Analysis.Iran J Med Sci. 2022 Jan;47(1):2-14. doi: 10.30476/ijms.2021.89475.2026. Iran J Med Sci. 2022. PMID: 35017772 Free PMC article.
-
[Ocular symptoms in SARS-CoV-2 infection].Pol Merkur Lekarski. 2022 Apr 19;50(296):86-93. Pol Merkur Lekarski. 2022. PMID: 35436269 Review. Polish.
-
Acute and sub-acute ocular manifestations in pediatric patients with COVID-19: A systematic review.Med Hypothesis Discov Innov Ophthalmol. 2022 Apr 1;11(1):11-18. doi: 10.51329/mehdiophthal1440. eCollection 2022 Spring. Med Hypothesis Discov Innov Ophthalmol. 2022. PMID: 37641695 Free PMC article. Review.
-
Ocular Manifestations of Chikungunya Infection: A Systematic Review.Pathogens. 2022 Mar 29;11(4):412. doi: 10.3390/pathogens11040412. Pathogens. 2022. PMID: 35456087 Free PMC article. Review.
Cited by
-
Spatiotemporal Characterization of Changes in the Respiratory Tract and the Nervous System, Including the Eyes in SARS-CoV-2-Infected K18-hACE2 Mice.Viruses. 2025 Jul 9;17(7):963. doi: 10.3390/v17070963. Viruses. 2025. PMID: 40733579 Free PMC article.
-
New-onset conjunctivitis 3.5 years post SARS-CoV-2 infection in an inner-city population in the Bronx.BMJ Open Ophthalmol. 2025 May 22;10(1):e001993. doi: 10.1136/bmjophth-2024-001993. BMJ Open Ophthalmol. 2025. PMID: 40404339 Free PMC article.
References
-
- Abrishami M., Tohidinezhad F., Daneshvar R., Omidtabrizi A., Amini M., Sedaghat A., et al. Ocular Manifestations of Hospitalized Patients with COVID-19 in Northeast of Iran. Ocul. Immunol. Inflamm. 2020;28(5):739–744. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Miscellaneous